171 related articles for article (PubMed ID: 27648075)
1. Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses.
Owens SD; Kol A; Walker NJ; Borjesson DL
Stem Cells Int; 2016; 2016():5830103. PubMed ID: 27648075
[TBL] [Abstract][Full Text] [Related]
2. Repeated intra-articular administration of equine allogeneic peripheral blood-derived mesenchymal stem cells does not induce a cellular and humoral immune response in horses.
Van Hecke L; Magri C; Duchateau L; Beerts C; Geburek F; Suls M; Da Dalt L; Patruno M; Saunders J; Broeckx SY; Depuydt E; Spaas JH
Vet Immunol Immunopathol; 2021 Sep; 239():110306. PubMed ID: 34365135
[TBL] [Abstract][Full Text] [Related]
3. Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.
Kol A; Wood JA; Carrade Holt DD; Gillette JA; Bohannon-Worsley LK; Puchalski SM; Walker NJ; Clark KC; Watson JL; Borjesson DL
Stem Cell Res Ther; 2015 Apr; 6(1):73. PubMed ID: 25888916
[TBL] [Abstract][Full Text] [Related]
4. Production of Cytotoxic Antibodies After Intra-Articular Injection of Allogeneic Synovial Membrane Mesenchymal Stem Cells With and Without LPS Administration.
Rosa GDS; Krieck AMT; Padula ET; Stievani FC; Rossi MC; Pfeifer JPH; Basso RM; Braz AMM; Golim MA; Alves ALG
Front Immunol; 2022; 13():871216. PubMed ID: 35572507
[TBL] [Abstract][Full Text] [Related]
5. Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.
Pezzanite LM; Fortier LA; Antczak DF; Cassano JM; Brosnahan MM; Miller D; Schnabel LV
Stem Cell Res Ther; 2015 Apr; 6(1):54. PubMed ID: 25889095
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies.
Berglund AK; Schnabel LV
Equine Vet J; 2017 Jul; 49(4):539-544. PubMed ID: 27862236
[TBL] [Abstract][Full Text] [Related]
7. Allo-antibody production after intraarticular administration of mesenchymal stem cells (MSCs) in an equine osteoarthritis model: effect of repeated administration, MSC inflammatory stimulation, and equine leukocyte antigen (ELA) compatibility.
Barrachina L; Cequier A; Romero A; Vitoria A; Zaragoza P; Vázquez FJ; Rodellar C
Stem Cell Res Ther; 2020 Feb; 11(1):52. PubMed ID: 32028995
[TBL] [Abstract][Full Text] [Related]
8. Cellular and Humoral Immunogenicity Investigation of Single and Repeated Allogeneic Tenogenic Primed Mesenchymal Stem Cell Treatments in Horses Suffering From Tendon Injuries.
Depuydt E; Broeckx SY; Chiers K; Patruno M; Da Dalt L; Duchateau L; Saunders J; Pille F; Martens A; Van Hecke L; Spaas JH
Front Vet Sci; 2021; 8():789293. PubMed ID: 35281431
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
Vet Immunol Immunopathol; 2013 Nov; 156(1-2):99-106. PubMed ID: 24094688
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints.
Ardanaz N; Vázquez FJ; Romero A; Remacha AR; Barrachina L; Sanz A; Ranera B; Vitoria A; Albareda J; Prades M; Zaragoza P; Martín-Burriel I; Rodellar C
BMC Vet Res; 2016 Mar; 12():65. PubMed ID: 27029614
[TBL] [Abstract][Full Text] [Related]
11. Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model.
Joswig AJ; Mitchell A; Cummings KJ; Levine GJ; Gregory CA; Smith R; Watts AE
Stem Cell Res Ther; 2017 Feb; 8(1):42. PubMed ID: 28241885
[TBL] [Abstract][Full Text] [Related]
12. Intra-Articular Injection of 2 Different Dosages of Autologous and Allogeneic Bone Marrow- and Umbilical Cord-Derived Mesenchymal Stem Cells Triggers a Variable Inflammatory Response of the Fetlock Joint on 12 Sound Experimental Horses.
Bertoni L; Branly T; Jacquet S; Desancé M; Desquilbet L; Rivory P; Hartmann DJ; Denoix JM; Audigié F; Galéra P; Demoor M
Stem Cells Int; 2019; 2019():9431894. PubMed ID: 31191689
[TBL] [Abstract][Full Text] [Related]
13. Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes.
Ranera B; Antczak D; Miller D; Doroshenkova T; Ryan A; McIlwraith CW; Barry F
Equine Vet J; 2016 Mar; 48(2):253-60. PubMed ID: 25582202
[TBL] [Abstract][Full Text] [Related]
14. The effects of therapeutic concentrations of gentamicin, amikacin and hyaluronic acid on cultured bone marrow-derived equine mesenchymal stem cells.
Bohannon LK; Owens SD; Walker NJ; Carrade DD; Galuppo LD; Borjesson DL
Equine Vet J; 2013 Nov; 45(6):732-6. PubMed ID: 23448189
[TBL] [Abstract][Full Text] [Related]
15. Effect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro.
Sherman AB; Gilger BC; Berglund AK; Schnabel LV
Stem Cell Res Ther; 2017 May; 8(1):120. PubMed ID: 28545510
[TBL] [Abstract][Full Text] [Related]
16. Procoagulant activity of human mesenchymal stem cells.
Christy BA; Herzig MC; Montgomery RK; Delavan C; Bynum JA; Reddoch KM; Cap AP
J Trauma Acute Care Surg; 2017 Jul; 83(1 Suppl 1):S164-S169. PubMed ID: 28628602
[TBL] [Abstract][Full Text] [Related]
17. In vitro MSC function is related to clinical reaction in vivo.
Rowland AL; Xu JJ; Joswig AJ; Gregory CA; Antczak DF; Cummings KJ; Watts AE
Stem Cell Res Ther; 2018 Nov; 9(1):295. PubMed ID: 30409211
[TBL] [Abstract][Full Text] [Related]
18. Preliminary evaluation of safety and migration of immune activated mesenchymal stromal cells administered by subconjunctival injection for equine recurrent uveitis.
Cassano JM; Leonard BC; Martins BC; Vapniarsky N; Morgan JT; Dow SW; Wotman KL; Pezzanite LM
Front Vet Sci; 2023; 10():1293199. PubMed ID: 38162475
[TBL] [Abstract][Full Text] [Related]
19. Anti-donor antibody induction following intramuscular injections of allogeneic mesenchymal stromal cells.
Alagesan S; Sanz-Nogués C; Chen X; Creane M; Ritter T; Ceredig R; O'Brien T; Griffin MD
Immunol Cell Biol; 2018 May; 96(5):536-548. PubMed ID: 29446493
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses.
Carrade DD; Owens SD; Galuppo LD; Vidal MA; Ferraro GL; Librach F; Buerchler S; Friedman MS; Walker NJ; Borjesson DL
Cytotherapy; 2011 Apr; 13(4):419-30. PubMed ID: 21105841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
